BACKGROUND: Information of the epidemiology of Major Depressive Episode (MDE) in Spain, one of the biggest southern European countries, is scarce and heterogeneous. The objective of this study was to assess the epidemiology of the disorder in the Spanish sample of the ESEMeD project. METHODS: The ESEMED-Spain project is a cross-sectional, general population, household survey conducted with a representative sample of Spanish non-institutionalized adult population. The survey instrument was the CIDI 3.0, a structured diagnostic interview to assess disorders and treatment. RESULTS: Lifetime prevalence was 10.6% while 12-month prevalence was 4.0%. A monotonic increase in lifetime overall prevalence was found from the youngest to the 50-64 cohort, declining then in the oldest group. Median age of onset was 30.0. Being a woman (OR=2.7), previously married (OR=1.8), unemployed or disabled to work (OR=2.9) was associated to higher risk of 12-month-MDE. The highest comorbid associations were with dysthymia (OR=73.1) and panic disorder (OR=41.8). LIMITATIONS: 1. Psychiatric diagnoses were made by trained lay interviewers and this could have an imperfect sensitivity/specificity; 2. Individuals with mental illness could have more frequently rejected to participate in the survey; 3. Age-related recall bias could have affected the accuracy of age of onset estimates. CONCLUSIONS: The study shows that prevalence MDE in Spain is lower than in other Western countries. Important findings are the early age of onset, the high proportion of chronicity, and the high female/male ratio. Taken together, results offer a complex picture of the epidemiology of MDE in Spain, when compared to other countries in Europe. The role of cultural factors is discussed.
BACKGROUND: Information of the epidemiology of Major Depressive Episode (MDE) in Spain, one of the biggest southern European countries, is scarce and heterogeneous. The objective of this study was to assess the epidemiology of the disorder in the Spanish sample of the ESEMeD project. METHODS: The ESEMED-Spain project is a cross-sectional, general population, household survey conducted with a representative sample of Spanish non-institutionalized adult population. The survey instrument was the CIDI 3.0, a structured diagnostic interview to assess disorders and treatment. RESULTS: Lifetime prevalence was 10.6% while 12-month prevalence was 4.0%. A monotonic increase in lifetime overall prevalence was found from the youngest to the 50-64 cohort, declining then in the oldest group. Median age of onset was 30.0. Being a woman (OR=2.7), previously married (OR=1.8), unemployed or disabled to work (OR=2.9) was associated to higher risk of 12-month-MDE. The highest comorbid associations were with dysthymia (OR=73.1) and panic disorder (OR=41.8). LIMITATIONS: 1. Psychiatric diagnoses were made by trained lay interviewers and this could have an imperfect sensitivity/specificity; 2. Individuals with mental illness could have more frequently rejected to participate in the survey; 3. Age-related recall bias could have affected the accuracy of age of onset estimates. CONCLUSIONS: The study shows that prevalence MDE in Spain is lower than in other Western countries. Important findings are the early age of onset, the high proportion of chronicity, and the high female/male ratio. Taken together, results offer a complex picture of the epidemiology of MDE in Spain, when compared to other countries in Europe. The role of cultural factors is discussed.
Authors: Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler Journal: Int J Methods Psychiatr Res Date: 2006 Impact factor: 4.035
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Joan Domènech-Abella; Elvira Lara; Maria Rubio-Valera; Beatriz Olaya; Maria Victoria Moneta; Laura Alejandra Rico-Uribe; Jose Luis Ayuso-Mateos; Jordi Mundó; Josep Maria Haro Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-02-02 Impact factor: 4.328
Authors: M C González-López; C M Rodríguez-López; T Parrón-Carreño; J D Luna; E Del Pozo Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2014-12-20 Impact factor: 4.328
Authors: J Alonso; G Vilagut; S Chatterji; S Heeringa; M Schoenbaum; T Bedirhan Üstün; S Rojas-Farreras; M Angermeyer; E Bromet; R Bruffaerts; G de Girolamo; O Gureje; J M Haro; A N Karam; V Kovess; D Levinson; Z Liu; M E Medina-Mora; J Ormel; J Posada-Villa; H Uda; R C Kessler Journal: Psychol Med Date: 2010-06-16 Impact factor: 7.723
Authors: Clara Maestre-Miquel; Ana López-de-Andrés; Zichen Ji; Javier de Miguel-Diez; Arturo Brocate; Sara Sanz-Rojo; Antonio López-Farre; David Carabantes-Alarcon; Rodrigo Jiménez-García; José J Zamorano-León Journal: Int J Environ Res Public Health Date: 2021-06-11 Impact factor: 3.390
Authors: José A Salinas-Pérez; Carlos R García-Alonso; Cristina Molina-Parrilla; Esther Jordà-Sampietro; Luis Salvador-Carulla Journal: Int J Health Geogr Date: 2012-08-24 Impact factor: 3.918